Skip to main content

Benitec Biopharma Inc.

BNTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001808898

No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Benitec Biopharma Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of BNTC: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders5672+16
Shares23.2M31.7M+8.51M (+36.7%)
Value$324.7M$426.6M+$101.8M (+31.4%)

New holders (20)

Institutions that held Benitec Biopharma Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to BNTC in Q4 2025
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.1,850,000$24.9M0.26%
Siren, L.L.C.775,000$10.4M0.31%
Alyeska Investment Group, L.P.750,000$10.1M0.03%
Balyasny Asset Management LLC651,558$8.78M0.02%
Millennium Management LLC613,160$8.26M0.01%
Burkehill Global Management, LP150,000$2.02M0.13%
Woodline Partners LP100,704$1.36M0.01%
Empery Asset Management, LP55,440$746.8K0.66%
Marshall Wace, LLP35,688$480.7K0.00%
Quadrature Capital Ltd31,481$424.0K0.00%
Persistent Asset Partners Ltd20,753$279.5K0.13%
Citadel Advisors LLC17,580$236.8K0.00%
Squarepoint Ops LLC15,045$202.7K0.00%
HRT Financial LP13,288$178.0K0.00%
Jane Street Group, LLC12,425$167.4K0.00%
SG Americas Securities, LLC8,232$111.0K0.00%
US Bancorp202$2.72K0.00%
Quadrant Capital Group LLC173$2.33K0.00%
Parallel Advisors, LLC55$7410.00%
Advisor Group Holdings, Inc.1$130.00%

Sold out (4)

Institutions that held Benitec Biopharma Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of BNTC in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
ExodusPoint Capital Management, LP77,912$1.09M
Simplex Trading, LLC72$1.00K
SRS Capital Advisors, Inc.24$337
SBI Securities Co., Ltd.1$14